HHS-2026-ACL-NIDILRR-BISA-0207
Small Business Innovation Research (SBIR) program, Phase I
Summary
ACL SBIR Phase I: Disability-Focused Innovation
The Administration for Community Living (ACL) seeks small business research to advance assistive technology, adaptive devices, and accessibility solutions that improve outcomes for people with disabilities. This Phase I SBIR program funds early-stage feasibility studies to validate the scientific and technical merit of concepts in disability research and development, rehabilitation engineering, and health technology translation. Successful projects will generate commercializable products or services—from biomedical innovations to accessibility tools—that translate ACL-supported research into market-ready solutions with direct social and economic benefit.
The program targets small businesses capable of bridging the gap between foundational disability science and practical, scalable interventions. Research may span computational approaches, device design, service delivery models, or implementation strategies across rehabilitation, assistive technology, and disability services domains.
- Who can apply: Small businesses (as defined by SBA standards); Phase I is open to companies new to the SBIR program or those meeting specific prior-award criteria.
- Funding & project length: 10 awards expected; 6-month project period with corresponding budget period.
- Award mechanism: Phase I SBIR grant (feasibility/proof-of-concept stage).
- Key dates: Not stated.
- Best fit for: Small firms in biomedical innovation, rehabilitation engineering, or assistive/accessibility technology seeking to validate early-stage concepts before Phase II commercialization.
Insights (5)
Small business structure requirement fundamentally reshapes team composition and IP strategy
This is an SBIR program, meaning applicants must be for-profit small businesses (≤500 employees) with primary R&D performed in-house. This excludes academic researchers, nonprofits, and large firms entirely—you cannot apply as a university or through a traditional academic institution. If your research group is embedded in academia, you must either spin out a company or partner with an existing small business as the prime applicant, which shifts control and IP ownership.
Disability-focused assistive technology commercialization aligns with SBIR's innovation-to-market mandate
ACL's SBIR explicitly targets R&D products with commercial application potential for disability services and adaptive devices. If your research addresses accessibility, rehabilitation engineering, or assistive technology with a clear path to market adoption, this program's focus on commercialization and economic return creates strong strategic fit. Preliminary evidence of market demand, user testing, or prototype validation will be particularly competitive.
Only 10 Phase I awards across all disability R&D topics creates high selectivity
With just 10 expected awards and a broad scope spanning multiple research fields (F36, F27, F17, F29, F22), competition is intense. Phase I SBIR grants are typically oversubscribed; you should assume a success rate under 15%. Differentiation requires not just technical merit but demonstrated commercial viability and a credible small-business team with relevant market expertise.
Phase I structure favors feasibility validation over mature commercialization
The 6-month Phase I timeline is designed to test scientific/technical merit and feasibility, not to deliver a market-ready product. This is advantageous for early-stage innovators with promising concepts but limited preliminary data—you don't need a fully developed prototype. However, you must demonstrate sufficient technical depth and market understanding to convince reviewers that Phase II (larger, longer grant) is justified.
Small business must retain R&D control; academic partnerships are secondary
Unlike traditional NIH grants, SBIR requires the small business to perform the majority of R&D in-house. Academic collaborators can support (e.g., testing, validation, domain expertise), but cannot be the prime applicant or lead the technical work. If your innovation depends on university lab infrastructure or faculty expertise, clarify upfront how you'll structure the partnership to maintain small-business primacy while accessing needed resources.
Key Facts
Deadline
—
Posted
Fri, September 5, 2025
Award Range
$95,000 – $100,000
Expected Awards
10
Keywords
Research Areas
Gotchas (2)
Project period and budget period are both fixed at 6 months with no flexibility mentioned, which is unusually restrictive compared to typical SBIR Phase I awards that often allow 6-12 months.
70%
Source Text
“Grants will have a 6-month project period with a corresponding six-month budget period.”
Only 10 grants will be awarded under this opportunity, creating extremely high competition that may not be typical for SBIR Phase I
70%
Source Text
“NIDILRR will make 10 grants under this opportunity.”